Elliot Cardiovascular Consultants, part of Elliot Health System (a founding member of SolutionHealth), have successfully implanted and activated the first LUX-Dx™ Insertable Cardiac Monitor System worldwide. Elliot Cardiovascular Consultants are members of the limited market release group. Cardiologist Dr. Tong Zhu was the first to implant, enroll, and remotely program the device, while simultaneously integrating the LATITUDE Clarity™ Data Management System with Epic, the health system’s electronic medical record, database.

 

The LUX-Dx Insertable Cardiac Monitor System is a new long-term diagnostic device recently approved by the FDA that is implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke, and syncope. It is designed with a dual-stage algorithm that detects and then verifies potential arrhythmias before an alert is sent to clinicians, thereby providing actionable data for clinical decision-making. Further, the remote programming capabilities of the device via the LATITUDE Clarity Data Management System website allow physicians and care teams to adjust event detection settings without requiring an in-person patient appointment, a feature unavailable on any other insertable cardiac monitor currently on the market.

 

Dr. Carl Fier, Medical Director of Cardiovascular Services, says this milestone is representative of a strong foundational partnership with Boston Scientific, the company that makes the new device. It is also representative of significant planning and strategizing in order to bring this device to the greater Manchester, New Hampshire community.

 

“Recognizing the advances that this insertable cardiac monitor brings to bear, and the understanding that these unique properties allow for a streamlined and much less labor-intensive process, Elliot physicians and their Boston Scientific partners were eager to begin offering the new device to their patients and those of other referring providers in the area,” says Dr. Fier. “We felt ready to be a member of the initial launch, in part because of our previous work and familiarity with the Boston Scientific Heart Logic algorithm and the infrastructure that had been built to effectively manage the data and clinically operationalize workflows to directly contribute to patient care.”